Loading...
SNAL is not a good buy right now for an impatient investor. The stock is in a clear downtrend (bearish moving averages, negative MACD) and the latest reported quarter (2025/Q3) shows sharp revenue decline and deepening losses, which outweigh near-term product-launch optimism. With no Intellectia buy signals today and price sitting near support, the setup looks more like a low-liquidity speculative bounce attempt than a high-conviction entry.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum is still negative (MACD histogram -0.00212 below zero), though it is negatively contracting, which can precede stabilization. RSI_6 is ~22.5 (oversold/washed-out conditions), so a short-term bounce is possible, but it would be counter-trend. Key levels: Current price ~0.715 is below S1 (0.729) and below the pivot (0.773), putting the stock in a weak technical position. Nearby support is S2 ~0.702; a break below that increases downside risk. Resistance sits at ~0.773 then ~0.816. Pattern-based projection provided: 70% chance of +0.6% next day, +3.25% next week, +4.03% next month—modest upside expectations that do not offset the broader bearish structure.
Intellectia Proprietary Trading Signals
Recent product/news momentum: Echoes of Elysium launched on Steam Early Access (pricing/discount may help initial uptake) and reportedly has 150,000+ wishlists, signaling notable user interest. Partnership with Loric Games may expand development capacity and align releases with market demand. Game design supports long-term content expansion, which could improve engagement and diversify revenue over time.
Financial deterioration in the latest quarter reported (2025/Q3): steep YoY revenue drop and significantly worse profitability/losses. Technical picture remains bearish (price below pivot and below key moving averages). No supportive positioning signals: hedge fund and insider activity described as neutral with no significant recent trends. No Intellectia buy signals today to override the weak setup. No recent congress trading data to indicate influential buying support.
Latest quarter: 2025/Q3. Revenue fell to 13,819,527 (-38.66% YoY). Net income was -7,864,541 (down -3444.52% YoY), with EPS -0.21 (down -2200% YoY). Gross margin reported at -0.39 (down -101.02% YoY), indicating severe profitability pressure. Overall: shrinking top line and worsening losses—negative growth trend into the most recent reported quarter.
Recent analyst action: (2025-11-13) Noble Capital lowered its price target to $3.00 from $3.50 while maintaining an Outperform rating, citing lower adjusted EBITDA expectations for 2026 after the Q3 report. Wall Street view (based on the single provided note): Pro—still sees upside versus the current sub-$1 price and maintains Outperform; Con—reduced target and lowered profitability expectations suggest weakening fundamentals and higher execution risk.